As part of our ongoing commitment to improve quality of care and reduce costs, the CDS Research Department acts in partnership with major pharmaceutical companies. A variety of research programs provide our patients with the newest medications and treatment modalities. All of our programs are thoroughly supervised and approved for use under guidelines set forth by the Food and Drug Administration. We encourage all of our patients to make informed choices about their medical care. Before participating in a research study, the patient must read, understand, and sign the patient consent form. The consent form describes the purpose, procedures, benefits, risks, discomforts, precautions, and alternative procedures. There is also information included about costs, compensation for medical treatment, and patient confidentiality. At no time does a patient lose his or her legal rights while participating in a research program. The rights of each patient are protected under the Institutional Review Board (IRB). All of this information is included in the patient consent form, and a copy of the consent will be provided to each patient enrolled in a study. By participating in a research study, patients may receive a variety of benefits. Although this will vary from study to study, some offer free office visits, free drugs, travel reimbursement, reduced costs for procedures, etc. This information is always included in the patient consent form, and we encourage patients to ask questions. Participating in the study does not alter medical care with CDS. The Research Department offers studies for high blood pressure, congestive heart failure, atrial fibrillation, high cholesterol and ventricular arrhythmias. It also provides access to the newest balloons, catheters, pacemakers and other techniques. If you are interested in participating in a research study, contact Shelley Holt via e-mail at shelley.holt@cdspc.com.